Maternal and congenital toxoplasmosis, currently available and novel therapies in horizon

Frontiers in Microbiology

Volumn 5, Issue JULY, 2014, Pages

  Oz, Helieh S ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Atovaquone; Congenital toxoplasmosis; Diclazuril; Fetal maternal; Mind alteration; Sexual transmission

Indexed keywords

ALPHA FETOPROTEIN; ANTIBODY; ATOVAQUONE; AZITHROMYCIN; CLARITHROMYCIN; COTRIMOXAZOLE; DAPSONE; DICLAZURIL; PYRIMETHAMINE PLUS SULFADOXINE; SPIRAMYCIN; TOXOPLASMA ANTIBODY; UNCLASSIFIED DRUG;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; CONGENITAL TOXOPLASMOSIS; CONTROLLED CLINICAL TRIAL (TOPIC); CROHN DISEASE; DRUG TARGETING; HUMAN; INFLAMMATORY BOWEL DISEASE; MENTAL DISEASE; MITOCHONDRIAL RESPIRATION; NONHUMAN; PREGNANT WOMAN; REVIEW; SEXUAL AROUSAL; SEXUALLY TRANSMITTED DISEASE; SYSTEMIC SCLEROSIS; TACHYZOITE; TOXOPLASMA; TOXOPLASMOSIS; TROPISM; ULCERATIVE COLITIS; WESTERN BLOTTING;

EID: 84905161630     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00385     Document Type: Review

References (71)

1. Arantes, T. P., Lopes, W. D., Ferreira, R. M., Pieroni, J. S., Pinto, V. M., Sakamoto, C. A.,et al. (2009). Toxoplasma gondii: evidence for the transmission by semen in dogs. Exp. Parasitol. 123, 190-194. doi: 10.1016/j.exppara.2009.07.003
2. Armstrong, L., Isaacs, D., and Evans, N. (2004). Severe neonatal toxoplasmosis after third trimester maternal infection. Pediatr. Infect. Dis. J. 23, 968-969. doi: 10.1097/01.inf.0000137573.08226.55
3. Assis, R. C., Luns, F. D., Beletti, M. E., Assis, R. L., Nasser, N. M., Faria, E. S.,et al. (2010). Histomorphometry and macroscopic intestinal lesions in broilers infected with Eimeria acervulina. Vet. Parasitol. 168, 185-189. doi: 10.1016/j.vetpar.2009.11.017
4. Avelino, M. M., Amaral, W. N., Rodrigues, I. M., Rassi, A. R., Gomes, M. B., Costa, T. L.,et al. (2014). Congenital toxoplasmosis and prenatal care state programs. BMC Infect. Dis. 14:33. doi: 10.1186/1471-2334-14-33
5. Bachmann, S., Schröder, J., Bottmer, C., Torrey, E. F., and Yolken, R. H. (2005). Psychopathology in first-episode schizophrenia and antibodies to Toxoplasma gondii. Psychopathology 38, 87-90. doi: 10.1159/000085349
6. Bessières, M. H., Berrebi, A., Cassaing, S., Fillaux, J., Cambus, J. P., Berry, A.,et al. (2009). Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis. Mem. Inst. Oswaldo Cruz 104, 389-392. doi: 10.1590/S0074-02762009000200038
7. Bierly, A. L., Shufesky, W. J., Sukhumavasi, W., Morelli, A. E., and Denkers, E. Y. (2008). Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection. J. Immunol. 18, 8485-8491. doi: 10.4049/jimmunol.181.12.8485
8. Boyer, K., Hill, D., Mui, E., Wroblewski, K., Karrison, T., Dubey, J. P.,et al. (2011). Toxoplasmosis study group. unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin. Infect. Dis. 53, 1081-1089. doi: 10.1093/cid/cir667
9. Brandtzaeg, P. (2001). Inflammatory bowel disease: clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses? Acta Odontol. Scand. 59, 235-243. doi: 10.1080/00016350152509265
10. Brown, A. S., Schaefer, C. A., Quesenberry, C. P Jr., Liu, L., Babulas, V. P., and Susser, E. S. (2005). Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am. J. Psychiatry 162, 767-773. doi: 10.1176/appi.ajp.162.4.767
11. Buxton, D., Thomson, K., Maley, S., Wright, S., and Bos, H. J. (1991). Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Vet. Rec. 129, 89-93. doi: 10.1136/vr.129.5.89
12. Carral, L., Kaufer, F., Olejnik, P., Freuler, C., and Durlach, R. (2013). Prevention of congenital toxoplasmosis in a Buenos Aires hospital. Medicina (B Aires). 73, 238-242.
13. Carter, C. J. (2013). Toxoplasmosis and polygenic disease susceptibility genes: extensive Toxoplasma gondii host/pathogen interactome enrichment in nine psychiatric or neurological disorders. J. Pathog. 2013:965046. doi: 10.1155/2013/965046
14. Cortina-Borja, M., Tan, H. K., Wallon, M., Paul, M., Prusa, A., Buffolano, W.,et al. (2010). European multicentre study on congenital toxoplasmosis (EMSCOT). Prenatal treatment for serious neurological squeal of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med. 7:e1000351. doi: 10.1371/journal.pmed.1000351
15. Dando, C., Gabriel, K. E., Remington, J. S., and Parmley, S. F. (2001). Simple and efficient method for measuring anti-toxoplasma immunoglobulin antibodies in human sera using complement-mediated lysis of transgenic tachyzoites expressing beta-galactosidase. J. Clin. Microbiol. 39, 2122-2125. doi: 10.1128/JCM.39.6.2122-2125.2001
16. di Carlo, P., Romano, A., Casuccio, A., Cillino, S., Schimmenti, M. G., Mancuso, G.,et al. (2011). Investigation and management of Toxoplasma gondii infection in pregnancy and infancy: a prospective study. Acta Pharmacol. Sin. 32, 1063-1070. doi: 10.1038/aps.2011.55
17. Dubey, J. P., and Jones, J. L. (2008). Toxoplasma gondii infection in humans and animals in the United States. Int. J. Parasitol. 38, 1257-1278. doi: 10.1016/j.ijpara.2008.03.007
18. Dubey, J. P., Lago, E. G., Gennari, S. M., Su, C., and Jones, J. L. (2012). Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology 139, 1375-424. doi: 10.1017/S0031182012000765
19. Dunay, I. R., Heimesaat, M. M., Bushrab, F. N., Muller, R. H., Stocker, H., Arasteh, K.,et al. (2004). Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Antimicrob. Agents Chemother. 48, 4848-4854. doi: 10.1128/AAC.48.12.4848-4854.2004
20. Dunn, D., Wallon, M., Peyron, F., Petersen, E., Peckham, C., and Gilbert, R. (1999). Mother-to child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet 353, 1829-1833 doi: 10.1016/S0140-6736(98)08220-8
21. Elsheikha, H. M., and Khan, N. A. (2010). Protozoa traversal of the blood brain barrier to invade the central nervous system. FEMS Microbiol. Rev. 34, 532-553. doi: 10.1111/j.1574-6976.2010.00215.x
22. Epple, H. J. (2009). Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease. Dig. Dis. 27, 555-559. doi: 10.1159/000233297
23. Erridge, C., Duncan, S. H., Bereswill, S., and Heimesaat, M. M. (2010). The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS ONE 5:e9125. doi: 10.1371/journal.pone.0009125
24. Fekadu, A., Shibre, T., and Cleare, A. J. (2010). Toxoplasmosis as a cause for behaviour disorders - overview of evidence and mechanisms. Folia Parasitol. 57, 105-113. doi: 10.14411/fp.2010.013
25. Flegr, J. (2013). Influence of latent toxoplasma infection on human personality, physiology and morphology: pros and cons of the toxoplasma-human model in studying the manipulation hypothesis. J. Exp. Biol. 216, 127-133. doi: 10.1242/jeb.073635
26. Freyre, A., Falcon, J., Mendez, J., and Gonzalez, M. (2008). Toxoplasma gondii: an improved rat model of congenital infection. Exp. Parasitol. 120, 142-146. doi: 10.1016/j.exppara.2008.06.007
27. Gilbert, R., and Gras, L. (2003). Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. Bjog 110, 112-120. doi: 10.1016/S1470-0328(02)02325-X
28. Gras, L., Wallon, M., Pollak, A., Cortina-Borja, M., Evengard, B., Hayde, M.,et al. (2005). Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr. 94, 1721-1731. doi: 10.1080/08035250500251999
29. Habib, F. A. (2008). Post-treatment assessment of acute toxoplasma infection during pregnancy. J. Obstet. Gynaecol. 28, 593-595. doi: 10.1080/01443610802344332
30. Hackstein, J. H., Mackenstedt, U., Mehlhorn, H., Meijerink, J. P., Schubert, H., and Leunissen, J. A. (1995). Parasitic apicomplexans harbor a chlorophyll a-D1 complex, the potential target for therapeutic triazines. Parasitol. Res. 81, 207-216.
31. Hoffmann, S., Batz, M. B., and Morris, J. G. Jr. (2012). Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J. Food Prot. 75, 1292-1302. doi: 10.4315/0362-028X.JFP-11-417
32. Hotez, P. J. (2008). Neglected infections of poverty in the United States of America. PLoS ONE 2:256. doi: 10.1371/journal.pntd.0000256
33. House, P. K., Vyas, A., and Sapolsky, R. (2011). Predator cat odors activate sexual arousal pathways in brains of Toxoplasma gondii infected rats. PLoS ONE 6:e23277. doi: 10.1371/journal.pone.0023277
34. Hudson, A. T., Dickins, M., Ginger, C. D., Gutteridge, W. E., Holdich, T., Hutchinson, D. B.,et al. (1991). 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Exp. Clin. Res. 17, 427-435. doi: 10.1371/journal.pone.0023277
35. Hughes, W., and Oz, H. S. (1995). Successful prevention and treatment of babesiosis with atovaquone. J. Infect. Dis. 172, 1042-1046. doi: 10.1093/infdis/172.4.1042
36. Jones, J. L., Lopez, A., Wilson, M., Schulkin, J., and Gibbs, R. (2001). Congenital toxoplasmosis: a review. Obstet. Gynecol. Surv. 56, 296-305. doi: 10.1097/00006254-200105000-00025
37. Kankova, S., Sulc, J., Krivohlavá, R., Kubena, A., and Flegr, J. (2012). Slower postnatal motor development in infants of mothers with latent toxoplasmosis during the first 18 months of life. Early Hum. Dev. 88, 879-884. doi: 10.1016/j.earlhumdev.2012.07.001
38. Kaur, M., and Verma, I. C. (1995). Serum alpha feto-protein screening in high risk pregnancies. Indian J. Pediatr. 62, 101-107. doi: 10.1007/BF02752193
39. Knight, K. (2013). How pernicious parasites turn victims into zombies. J. Exp. Biol. 1, 216i-216iv.
40. Köhler, S., Delwiche, C. F., Denny, P. W., Tilney, L. G., Webster, P., Wilson, R. J. M.,et al. (1997). A plastid of probable green algal origin in apicomplexan parasites. Science 275, 1485-1489. doi: 10.1126/science.275.5305.1485
41. Lidar, M., Langevitz, P., Barzilai, O., Ram, M., Porat-Katz, B. S., Bizzaro, N.,et al. (2009). Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann. N. Y. Acad. Sci. 1173, 640-648. doi: 10.1111/j.1749-6632.2009.04673.x
42. Lige, B., Sampels, V., and Coppens, I. (2013). Characterization of a second sterol-esterifying enzyme in toxoplasma highlights the importance of cholesterol storage pathways for the parasite. Mol. Microbiol. 87, 951-967. doi: 10.1111/mmi.12142
43. Lopes, W. D., Rodriguez, J. D., Souza, F. A., dos Santos, T. R., dos Santos, R. S., Rosanese, W. M.,et al. (2013). Sexual transmission of Toxoplasma gondii in sheep. Vet. Parasitol. 195, 47-56. doi: 10.1016/j.vetpar.2012.12.056
44. McLeod, R., Boyer, K., Karrison, T., Kasza, K., Swisher, C., Roizen, N.,et al. (2006). Outcome of treatment for congenital toxoplasmosis, 1981-2004: the national collaborative chicago-based, congenital toxoplasmosis study. Clin. Infect. Dis. 42, 1383-1394. doi: 10.1086/501360
45. Mead, P. S., Slutsker, L., Dietz, V., McCaig, L. F., Bresee, J. S., Shapiro, C.,et al. (1999). Food-related illness and death in the United States. Emerg. Infect. Dis. 5, 606-625.
46. Mizejewski, G. J. (2007). Physiology of alpha-fetoprotein as a biomarker for perinatal distress: relevance to adverse pregnancy outcome. Exp. Biol. Med. 232, 993-1004. doi: 10.3181/0612-MR-291
47. Muzzio, D. O., Soldati, R., Rolle, L., Zygmunt, M., Zenclussen, A. C., and Jensen, F. (2014). B-1a B cells regulate T cell differentiation associated with pregnancy disturbances. Front. Immunol. 5:6. doi: 10.3389/fimmu.2014.00006
48. Norwitz, E. R., Schust, D. J., and Fisher, S. J. (2001). Implantation and the survival of early pregnancy. N. Engl. J. Med. 345, 1400-1408. doi: 10.1056/NEJMra000763
49. Olariu, T. R., Remington, J. S., and Montoya, J. G. (2014). Polymerase chain reaction in cerebrospinal fluid for the diagnosis of congenital toxoplasmosis. Pediatr. Infect. Dis. J. 33, 566-570. doi: 10.1097/INF.0000000000000256
50. Oz, H. S. (2014). "Fetal and maternal toxoplasmosis," in Recent Advances in Toxoplasmosis Research, 1st Edn, Chap. 1, ed. C. M. Lee (Lexington, KY: Nova Science Publication), 1-33.
51. Oz, H. S., Chen, T., and de Villiers, W. (2013). Green tea polyphenols and sulfasalazine have parallel anti-inflammatory properties in colitis models. Front. Immunol. 4:132. doi: 10.3389/fimmu.2013.00132
52. Oz, H. S., Chen, T., and Ebersole, J. L. (2009). A model for chronic mucosal inflammation in IBD and periodontitis dig. Dis. Sci. 55, 2194-2202. doi: 10.1007/s10620-009-1031-x
53. Oz, H. S., and Ebersole, J. L. (2009). Application of prodrugs to inflammatory diseases of the gut. Molecules 13, 452-474. doi: 10.3390/molecules13020452
54. Oz, H. S., and Tobin, T. (2012). Atovaquone ameliorates gastrointestinal toxoplasmosis complications in a pregnancy model. Med. Sci. Mon. 18, BR337-BR345. doi: 10.12659/MSM.883342
55. Oz, H. S., and Tobin, T. (2014). Diclazuril protects against maternal gastrointestinal syndrome and congenital toxoplasmosis. Int. J. Clin. Med. 5, 93-101. doi: 10.4236/ijcm.2014.53017
56. Oz, H. S., and Westlund, K. H. (2012). "Human Babesiosis" an emerging transfusion dilemma. Int. J. Hepatol. 2012:431761. doi: 10.1155/2012/431761
57. Pedersen, M. G., Mortensen, P. B., Norgaard-Pedersen, B., and Postolache, T. T. (2012). Toxoplasma gondii infection and self-directed violence in mothers. Arch. Gen. Psych. 69, 1123-1130. doi: 10.1001/archgenpsychiatry.2012.668
58. Petersen, E., and Schmidt, D. R. (2003). Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? Expert Rev. Anti Infect. Ther. 1, 175-182. doi: 10.1586/14787210.1.1.175
59. Portugal, L. R., Fernandes, L. R., and Alvarez-Leite, J. I. (2009). Host cholesterol and inflammation as common key regulators of toxoplasmosis and artherosclerosis development. Expert Rev. Anti Infect. Ther. 7, 807-819. doi: 10.1586/eri.09.60
60. Remington, J. S., McLeod, R., Thulliez, P., and Desmonts, G. (2006). "Toxoplasmosis," in Infectious Diseases of the Fetus and Newborn Infant, 6th Edn, eds J. S. Remington, J. O. Klein, C. B. Wilson, and C. J. Baker (Philadelphia, PA: Elsevier Saunders), 947-1091. doi: 10.1016/B0-72-160537-0/50033-5
61. Rolan, P. E., Mercer, A. J., Tate, E., Benjamin, I., and Posner, J. (1997). Disposition of atovaquone in humans. Antimicrob. Agents Chemother. 41, 1319-1321.
62. Scallan, E., Hoekstra, R. M., Angulo, F. J., Tauxe, R. V., Widdowson, M-A., Roy, S. L.,et al. (2011). Foodborne illness acquired in the United States major pathogens. Emerg. Infect. Dis. 17, 7-15. doi: 10.3201/eid1701.P11101
63. Shapira, Y., Agmon-Levin, N., Selmi, C., Petríková, J., Barzilai, O., Ram, M.,et al. (2012). Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases. J. Autoimmun. 39, 112-116. doi: 10.1016/j.jaut.2012.01.001
64. Srivastava, I. K., and Vaidya, A. B. (1999). A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Antimicrob. Agents Chemother. 43, 1334-1339.
65. Teixeira, L. E., Kanunfre, K. A., Shimokawa, P. T., Targa, L. S., Rodrigues, J. C., Domingues, W.,et al. (2013). The performance of four molecular methods for the laboratory diagnosis of congenital toxoplasmosis in amniotic fluid samples. Rev. Soc. Bras Med. Trop. 46, 584-588. doi: 10.1590/0037-8682-0095-2013
66. Torrey, E. F., Bartko, J. J., Lun, Z. R., and Yolken, R. H. (2007). Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr. Bull. 33, 729-736. doi: 10.1093/schbul/sbl050
67. Wanderley, F. S., Porto, W. J., Câmara, D. R., da Cruz, N. L., Feitosa, B. C., Freire, R. L.,et al. (2013). Experimental vaginal infection of goats with semen contaminated with the "CPG" strain of Toxoplasma gondii. J. Parasitol. 99, 610-613. doi: 10.1645/12-126.1
68. Wang, H. L., Wang, G. H., Li, Q. Y., Shu, C., Jiang, M. S., and Guo, Y. (2006). Prevalence of toxoplasma infection in first-episode schizophrenia and comparison between toxoplasma-seropositive and toxoplasma-seronegative schizophrenia. Acta Psychiatr. Scand. 114, 40-48. doi: 10.1111/j.1600-0447.2006.00780.x
69. Wolf, A., Cowen, D., and Paige, B. (1939). Human toxoplasmosis: occurrence in infants as an encephalomyelitis verification by transmission to animals. Science 89, 226-227. doi: 10.1126/science.89.2306.226
70. Zhang, Y., Traskman-Bendz, L., Janelidze, S., Langenberg, P., Saleh, A., Constantine, N.,et al. (2012). Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J. Clin. Psychiatry 73, 1069-1076. doi: 10.4088/JCP.11m07532
71. Zhou, W., Quan, J. H., Lee, Y. H., Shin, D. W., and Cha, G. H. (2013). Toxoplasma gondii proliferation require down-regulation of host nox4 expression via activation of PI3 kinase/akt signaling pathway. PLoS ONE 8:e66306. doi: 10.1371/journal.pone.0066306